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Abstract 
 
Acute kidney injury (AKI) is the common clinical syndrome which is associated with increased morbidity and 
mortality. The severity extends from less to more advanced spectrums which link to biological, physical and chemical agents. 
Oxidative stress (OS)-related AKI has demonstrated the increasing of reactive oxygen species (ROS) and reactive nitrogen 
species (RNS) and the decreasing of endogenous antioxidants. Medicinal plants-derived antioxidants can be ameliorated 
oxidative stress-related AKI through reduction of lipid peroxidation (LPO) and enhancement of activities and levels of 
endogenous antioxidants. Therefore, medicinal plants are good sources of exogenous antioxidants which might be considered 
the important remedies to ameliorate pathological alterations in oxidative stress-related AKI. 
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Introduction 
 
Kidney functions are excretions of waste products and toxins from blood circulation (approximately 20-25% from 
cardiac output), preservative of bodily fluids and electrolytes homeostasis, and regulation of blood pressure and hormone 
secretions. Counteraction of toxic substances in bloodstream against vessels, glomeruli and tubules of kidneys results in 
disruptions of renal architectures and functions. Acute kidney injury (AKI) is the common clinical complication which is 
associated with increased morbidity and mortality, affecting about 1-7% of hospitalised patients and 1-25% of patients in the 
intensive care unit (ICU) (de Mendonça et al. 2000; Nash et al. 2002). In clinical, AKI is a rapid reduction in kidney 
function, causing failure to maintain fluid, electrolyte and acid-base homeostasis. The Risk, Injury, Failure, Loss, and End-
stage Kidney (RIFLE) classification proposed by the Acute Dialysis Quality Initiative (ADQI) group divides AKI into five 
stages, as follows: (1) Risk; (2) Injury; (3) Failure; (4) Loss of function; and (5) End stage kidney disease (ESKD) (Van 
Biesen et al. 2006; Bellomo et al. 2007) (Table 1).  
 
 
Table 1: The Risk, Injury, Failure, Loss, and End-stage Kidney (RIFLE) classification of acute kidney injury (Bellomo et al., 
2007) 
 
Stage Glomerular filtration rate (GFR) criteria Urine output (UO) criteria 
 
Risk 
 
Increased serum creatinine 1.5 times or GFR decrease > 
25%  
 
 
< 5 mL/kg/h for 6 h 
Injury Increased serum creatinine  2 times or 
GFR decrease > 50% 
 
< 5 mL/kg/h for 12 h 
Failure Increased serum creatinine 3 times or 
GFR decrease > 75% or serum creatinine  > 4 mg/dL 
< 3 mL/kg/h for 24 h or anuria for 12 h 
 
Loss 
 
 
Complete loss of kidney function > 4 weeks 
ESKD End stage kidney disease (> 3 months) 
 
 
 
Recently, the Acute Kidney Injury Network (AKIN) developed a new system for staging AKI which stages 1, 2 and 
3 were corresponded with the risk, injury and failure categories (Table 2). The severity extends from less to more advanced 
spectrums which link to biological, physical and chemical agents. Ischemia and sepsis are common causative factors of AKI 
(Mehta et al., 2004). Functional and structural alterations of renal microvasculature are important processes contributing to 
the pathophysiology of AKI. The persistent deficit in renal blood flow has been posited to be intrinsically linked to tubular 
injury, inflammation and vascular alterations (Sutton 2009). In sepsis, AKI is triggered by both ischemic and inflammatory 
components, leading to the loss of renal epithelial cells and tubular cell dysfunction. Oxidative stress (OS) is the most 
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important factor that is associated with various pathologies during AKI. This review emphasises the activities of antioxidants 
from phytochemical constituents of medicinal plants to insult OS-associated pathologies in AKI. 
 
Table 2: The Acute Kidney Injury Network (AKIN) classification of acute kidney injury (Mehta et al., 2007) 
Stage Kidney functions Urine output 
 
1 
 
Increase in serum creatinine ≥ 0.3 mg/dL or increase 
 To ≥ 150-199% (1.5-1.9 folds) from baseline 
 
< 0.5 mL/kg/h for ≥ 6 h 
 
 
2 Increase in serum creatinine to 200-299% (> 2-2.9 folds) from baseline < 0.5 mL/kg/h for ≥ 12 h 
 
 
3 Increase in serum creatinine to ≥ 300% (≥ 3 folds) from baseline or 
serum creatinine ≥ 4 mg/dL with an acute rise of at least 0.5 mg/dL or 
initiation of renal replacement therapy 
 
< 0.3 mL/kg/h ≥ 24 h 
or anuria ≥ 12 h 
 
 
Oxidative stress and antioxidant defence system 
 
OS is an imbalance among the rate of production and removal of oxidant and common causative factor of various 
diseases such as ischemia, atherosclerosis, neurodegenerative diseases and aging (Sorg 2004; Salmon et al., 2010). OS-
mediated molecules are ROS and RNS (Sorg 2004). ROS are several reactive molecules and free radicals derived from 
molecular oxygen as illustrated in Fig.1. The most important ROS are consisted of superoxide anion (O2•-), hydroxyl radical 
(•OH), hydrogen peroxide (H2O2); and hypochlorous acid (HOCl). These species are involved in the regulation of 
fundamental cellular activities. At high concentration, ROS are the highly reactive molecules that are able to become toxic to 
macromolecules, including lipid, protein and DNA, and hence, cause disruption of the cellular structural integrity and 
capacity. ROS are produced in both endogenous and exogenous sources. Endogenous sources are consisted of mitochondrial 
electron transport chain, phagocytes (respiratory burst), oxidant enzyme (xanthine oxidase), and auto-oxidation reaction 
(Young & Woodside 2001; Valko et al., 2007). Environmental agents include radiations, xenobiotics, chlorinated 
compounds, cigarettes and alcohols (Ziech et al., 2010). RNS are by-products of nitric oxide (•NO), which plays a key role in 
maintaining various physiological functions but can also contribute to several pathological processes at high levels. RNS are 
comprised of nitrite (NO2-), nitrate (NO3-) and peroxynitrite (ONOO-). To prevent ROS/RNS-caused cellular damage, the 
body has a defence system called antioxidant. 
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Figure 1: Generation of ROS and RNS (modified from Valko et al., 2007). Note: superoxide anions (O2•-); hydroxyl radical 
(•OH); hydrogen peroxide (H2O2); hypochlorous acid (HOCl); peroxynitrite (ONOO-); nitric oxide (•NO); nitric oxide 
synthase (NOS); superoxide dismutase (SOD); myeloperoxidase (MPO); glutathione peroxidase (GPx); glutathione reductase 
(GR); reduced glutathione (GSH); oxidized glutathione (GSSG); nicotinamide adenine dinucleotide phosphate (NADPH); 
ferric (Fe3+); and ferrous  (Fe2+) 
Antioxidant systems prevent uncontrolled formation of free radicals and activated oxygen species, or inhibit their 
reactions with biological structures (Riley 1994). Antioxidants are any substances which can inhibit the oxidation of 
oxidative substrates (Halliwell 1995). They have several molecules that play a role in antioxidant defence, including 
endogenous (internally synthesised) and exogenous (consumed) antioxidants. They can be divided into two types depending 
on mechanism of action, either chain breaking antioxidants or preventive antioxidants (Benzie & Strain 1999). Preventive 
antioxidants reduce the rate of chain initiation by deactivating metals, quenching singlet oxygen and removing 
hydroperoxides, including transferrin, ferritin, ethylenediaminetetraacetic acid (EDTA), ceruloplasmin, catalase, SOD and 
GPx. Whereas, chain breaking antioxidants are the molecules that have the ability to receive or donate an electron from a 
radical with the formation of stable byproducts including α-tocopherol, ascorbic acid, uric acid and β-carotene (Halliwell 
1995; Young & Woodside 2001).  
 
Medicinal plants-derived antioxidants 
  
Medicinal plants are used for the treatment of various diseases in several decades. They were shown to be good, 
effective, inexpensive, safe, and available. Current researches and financial supports have shown increased interest in their 
advantage. Currently, extraction and development of several drugs and chemotherapeutics from these plants have been 
widely observed. Medicinal plants have always been considered a healthy source for the prevention of various OS-related 
diseases (Sailaja & Setty 2006; Olaleye & Rocha 2008; Qin et al., 2009; Reddy et al., 2009; Marnewick et al., 2011; Sen et 
al., 2011; Keter & Mutiso 2012). They compose a wide variety of phytochemical constituent molecules that have the 
antioxidant properties including carotenoids and phenolic compounds (Auddy et al., 2003; Bouayed et al., 2007; Huang et al., 
2010; Awah et al., 2012). Carotenoids are categorised as tetraterponoids, which are divided into two major structural groups: 
(1) molecules containing oxygen, xanthophylls such as lutein and β-cryptoxanthin, and (2) un-oxygenated carotenes which 
include hydrocarbon carotenoids that are either cyclised such as α-carotene and β-carotene or linear, like lycopene (Mein et 
al., 2011). They have demonstrated antioxidant activity such as chain breaking antioxidants (Bast et al., 1998; Palace et al., 
1999). High carotenoid intakes have a significantly reduced risk of several chronic and degenerative diseases (Cooper et al., 
1999; Rao & Agarwal 2000; Rao & Rao 2007). While, phenolic compounds are mainly consisted of flavonoids, tannin and 
phenolic acids usually found in medicinal plants and food products. Flavonoids constitute the largest group of plant 
phenolics, including anthocyanidin, anthochlors, auronus, flavonones, dihydroflavone, flavone, flavonols and isoflavonoid 
which also display a wide range of antioxidant properties (Reyes et al., 2005; Azevedo et al., 2010; Martins et al., 2011; Qin 
et al., 2011). Phenolic acids constitute also an important antioxidant of phenolic compounds which can be divided into two 
subgroups: hydroxybenzoic or hydroxycinnamic acids (Sroka & Cisowski 2003; Cheng et al., 2007; Martins et al., 2011).   
 
Protective effect of medicinal plants-derived antioxidants in OS-related AKI 
  
Kidney damage in OS-related AKI was associated with increased ROS/RNS production, leading to oxidation of 
several macromolecules (e.g. protein, DNA and lipid). Production of lipid peroxidation (LPO) in OS-related AKI results in 
large production of secondary products such as malondialdehye (MDA) and 4-hydroxynonenal (Cristol et al., 1996). LPO 
refers to the oxidation of lipids particularly polyunsaturated fatty acids by mechanism of free radical chain reaction. Like 
ROS/RNS, resulting lipid peroxides are dangerous to cells due to its ability to sustain free radical cascades, eventually 
leading to increased membrane rigidity and abnormalities of endothelial function which may be involved in the 
pathophysiology of AKI (Pieper et al., 1997; Farooqui & Horrocks 1998). Moreover, OS-related AKI was significantly 
reduced by endogenous antioxidants (Seok et al., 2007; Ghule et al., 2011). GR-deficient mice were used to demonstrate 
ROS-mediated renal proximal tubule injury (Rogers et al., 2006). Medicinal plants-derived antioxidants ameliorated kidney 
against OS during AKI as summarised in Table 3.  
Medicinal plants-derived antioxidants can be protected against renal damage through reduced LPO and increased 
endogenous antioxidants. Increased activities and levels of endogenous antioxidants are the key factors to reduced OS-
induced AKI. Endogenous antioxidants are mainly comprised of SOD, catalase, GPx, GR and GSH. SOD converts O2•- into 
H2O2 as shown in Fig. 1. There are 3 forms of SOD in mammalian tissues depending on a specific subcellular location and 
different tissue distribution including copper zinc-SOD (found in the cytoplasm and organelles), manganese-SOD (found in 
the mitochondria) and extracellular SOD (expressed on the cell surface) (Young & Woodside 2001). Catalase is an 
endogenous antioxidant enzyme which protects body from OS by converting H2O2 into water and oxygen. It is highly 
abundant within peroxisomes, which also contain most of enzymes capable of generating H2O2. The amount of catalase in 
cytoplasm and other subcellular compartments remain unclear, because peroxisomes are easily ruptured during the 
manipulation of cells. The most activity is present in liver and the red blood cell (Young & Woodside 2001). GPx is known 
as primary antioxidant in the body and is believed to synthesise mainly in kidney (Roxborough et al., 1999). The highest 
concentrations are found in the liver. The predominant subcellular distribution is found in cytosol and mitochondria, 
suggesting that GPX is the main scavenger of H2O2 in those compartments. GR is an important cellular enzyme which 
converts GSSG into GSH as illustrated in Figure 1.  
Cells that are exposed to high levels of OS are needed for this reaction. Augusti et al., (2008) demonstrated the 
protective role of astaxanthin against mercury nephrotoxicity by reducing OS. A carotenoid, astaxanthin is able to prevent the 
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increased LPO and protein oxidation and attenuate histopathological changes caused by mercuric chloride in kidney. In 
addition, it can protect the depression of SOD activity (Augusti et al., 2008). Khan et al., (2010) provide evidence that 
potassium dichromate administration caused nephrotoxicity in both proximal tubule and glomerulus through OS induction. 
Tocotrienol, a member of vitamin E family, supplementation exhibited the capacity to reduce proximal tubular injury and 
renal LPO, and increased GSH level and catalase activity. Moreover, it is able to improve the index of NO2-/NO3- generation. 
 
 
Table 3: Mechanism of medicinal plants-derived antioxidants ameliorated kidney against oxidative stress during AKI 
Antioxidants Mechanism to prevent oxidative stress-induced AKI References 
 
Astaxanthin 
 
- Increased SOD activity 
- Reduced protein and LPO 
 
 
(Augusti et al., 2008) 
Tocotrienol - Increased GSH level,  catalase activity in the renal cortex 
- Increased urinary excretion of NO 
- Reduced renal LPO 
 
(Khan et al., 2010) 
Phenolics - Decreased renal xanthine oxidase activity and serum nitrate/ nitrite 
- Increased the activities of SOD, catalase, glutathione-S-transferase and 
glucose-6-phosphatase 
- Reduction of renal LPO 
 
(Ekor et al., 2010) 
Ligustrazine - Reduced MPO activity 
- Increased SOD activity 
- Reduced renal LPO 
 
(Feng et al., 2011) 
Troxerutin - Increased SOD, CAT and GPx activity 
- Reduced renal LPO 
(Fan et al., 2009) 
 
The investigation suggested that tocotrienol can be considered a natural antioxidant supplement protecting the kidney 
pathology induced by potassium dichromate (Khan et al., 2010). Ligustrazine is an alkaloid extracted from Ligusticum 
wallichii which exhibited the scaveging properties of ROS. Feng et al., (2011) demonstrated the ability of ligustrazine to 
protect kidneys from warm ischemia/reperfusion injuries by decreasing ROS generation, reducing MDA, a lipid peroxidation 
biomarker and elevating SOD activity (Feng et al., 2011). Fan et al., (2009) illustrate the effectively antioxidant activity of 
troxerutin to attenuate the renal injury induced by D-galactose in mice. Troxerutin, a rutoside derivative, is found abundant in 
tea, coffee, cereal grain and a variety of fruits and vegetables elicited the ability to elevate antioxidant enzyme activities, 
including Cu/Zn SOD, GPx and catalase and to reduce MDA level (Fan et al., 2009). Recent studies by Palipoch et al., 
(2011) indicated that leaf extract of Thai herb, Thunbergia laurifolia, has the ability to reduce OS-associated kidney damage 
induced by lead (II) nitrate in fish. Supplementation of T. laurifolia leaf extracts is able to increase the activities of intrinsic 
antioxidant, including GSH, GPx, GR and catalase and able to deplete LPO, ultimately reducing kidney pathology. They 
suggested that constituents in leaf extract including chlorophyll derivatives, apigenin and caffeic acid may act as antioxidant 
(Palipoch et al., 2011a, b).  
 
 
Conclusion 
  
OS is one of the important factors contributing to AKI by increasing production of oxidants, particularly ROS and 
RNS and/or ineffective/insufficiency of endogenous antioxidant defence system. Medicinal plant-derived exogenous 
antioxidants are demonstrated to ameliorate AKI-induced OS by reduced LPO and enhanced oxidant scavenging ability of 
antioxidant defence system. We suggested that supplementation of antioxidant obtained from medicinal plants might be 
considered the important remedy to abrogate pathology of OS-related AKI.    
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